Furthermore, the CIS myoblasts exhibited impaired myotube differentiation ability and decreased expressions of MyoD1, myogenin, and MHC as well as a decreased ratio of p-AKT1 (ser473)/AKT1 compared to the NOR myoblasts. This evidence concerns the gene MYOD1 and in situ carcinoma.